Search | TVST | ARVO Journals

Showing 1 – 20 of 108

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2022

Incidence, Risk Factors and Outcomes of Submacular Hemorrhage with Loss of Vision in Neovascular Age-Related Macular Degeneration in Daily Clinical Practice: the Fight Retinal Blindness! Registry

Pierre-Henry GABRIELLE; Vuong Nguyen; Jennifer J Arnold; David Squirrell; Louis Arnould; Jorge Sanchez-Monroy; Francesco Viola; Louise O’ Toole; Daniel Barthelmes; Catherine Creuzot-Garcher; Mark C Gillies

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1344 – F0178. doi:

ARVO Annual Meeting Abstract June 2022

Jak/STAT signalling mediated glia-neuron interaction following MAPK inhibition

Shaoxue Zeng; Ting Zhang; Yingying Chen; Kaiyu Jin; Xiaohui Fan; Ling Zhu; Mark C Gillies

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1176 – A0030. doi:

ARVO Annual Meeting Abstract June 2022

Reprogramming of serine and glycine synthesis pathway in the JR5558 mouse model of retinal fibrosis

Ting Zhang; Ling Zhu; So-Ra Lee; Shaoxue Zeng; Yingying Chen; Michelle Yam; Mark C Gillies

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2478 – F0185. doi:

ARVO Annual Meeting Abstract June 2022

Metallothionein is activated specifically in Müller cells in response to retinal stress

Ling Zhu; Ting Zhang; Kaiyu Jin; Shaoxue Zeng; Yingying Chen; So-Ra Lee; Michelle Yam; Fanfan Zhou; Xiaohui Fan; Mark C Gillies

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):4122 – F0359. doi:

ARVO Annual Meeting Abstract June 2022

36-month outcomes of VEGF inhibitors for treatment-naïve Central Retinal Vein Occlusion: Data from the Fight Retinal Blindness! registry.

Adrian Hunt; Vuong Nguyen; Sanjeeb Bhandari; Jennifer J Arnold; Ian McAllister; Hemal Mehta; Alessandro Invernizzi; David Squirrell; Theodorus Ponsioen; Pierre-Henry GABRIELLE; Louise O’ Toole; Javier Zarranz-Ventura; Daniel Barthelmes; Mark C Gillies

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2674. doi:

Articles November 2021

Three-Year Outcomes of Neovascular Age-Related Macular Degeneration in Eyes That Do Not Develop Macular Atrophy or Subretinal Fibrosis

PDF

Pierre-Henry Gabrielle; Vuong Nguyen; Jennifer J. Arnold; Sanjeeb Bhandari; Francesco Viola; Odette A. M. Tigchelaar-Besling; Gonzaga Garay-Aramburu; Louise O'Toole; Chui Ming Gemmy Cheung; Daniel Barthelmes; Catherine Creuzot-Garcher; Mark Gillies
TAGS: atrophoderma maculatum, exudative age-related macular degeneration, eye, fibrosis
Trans. Vis. Sci. Tech.. 2021; 10(13):5. doi: https://doi.org/10.1167/tvst.10.13.5

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2021

Extending interoperability in ophthalmology through Fast Healthcare Interoperability Resource (FHIR)

Ashley Kras; Warren Oliver; Mark C Gillies; Michael Mair; Stephen Chu; Nigel Morlet; Michael Mbagwu; Thomas S Hwang; Matthew Roe; Theordore Leng

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1708. doi:

ARVO Annual Meeting Abstract June 2021

Disruption of the pentose phosphate pathway in Müller cells makes them more susceptible to light stress by interfering with the oxidative stress-induced NRF2 response

Yingying Chen; Ting Zhang; Shaoxue Zeng; Kaiyu Jin; Rong Xu; Xiaohui Fan; Meixia Zhang; Jianhai Du; Mark C Gillies; Ling Zhu

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1667. doi:

ARVO Annual Meeting Abstract June 2021

JR5558 transgenic mice are a reliable model to investigate subretinal fibrosis

Yashar Seyed-Razavi; So-Ra Lee; Jiawen Fan; Weiyong Shen; Mark C Gillies

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):2253. doi:

ARVO Annual Meeting Abstract June 2021

Quality of life impact of eye diseases: a Save Sight Registries study

Himal Kandel; Vuong Nguyen; Mark C Gillies; Stephanie L Watson

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3495. doi:

ARVO Annual Meeting Abstract June 2021

COVID-19 pandemic lockdown international impact on nAMD, DME and RVO intravitreal therapy outcomes: Fight Retinal Blindness International registry

Javier Zarranz-Ventura; Vuong Nguyen; Catherine P Creuzot Garcher; Frank D Verbraak; Louise OToole; Alessandro Invernizzi; Francesco Viola; David Squirrell; Daniel Barthelmes; Mark C Gillies

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):311. doi:

ARVO Annual Meeting Abstract June 2021

Variation in visual outcomes for neovascular age-related macular degeneration within and between practitioners

Vuong Nguyen; Daniel Barthelmes; Mark C Gillies

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):455. doi:

ARVO Annual Meeting Abstract June 2020

Disease Activity Assessments with Brolucizumab vs Aflibercept in Patients with nAMD in HAWK and HARRIER

Rishi P Singh; Robin Hamilton; Jeffrey S Heier; Carl Regillo; Mark C Gillies; Georges Weissgerber; Jahangir Alam; Pravin U Dugel

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1158. doi:

ARVO Annual Meeting Abstract June 2020

Towards retinal regeneration: Reprogramming retinal glial cells into photoreceptors using CRISPRa

Raymond Wong; Tu Nguyen; Lyujie Fang; Sam Lukowski; Camden Lo; Sandy Hung; Chi D Luu; Mark C Gillies; Alex W Hewitt

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2497. doi:

ARVO Annual Meeting Abstract June 2020

PD98059 inhibits the activation of mitogen-activated protein kinase in stressed Müller cells and protects photoreceptor from degeneration

Shaoxue Zeng; Ting Zhang; Michele C Madigan; Riccardo Carlo Natoli; Junjun Zhang; Nilisha Fernando; Joshua Aaron Chu-Tan; Ling Zhu; Mark C Gillies

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3219. doi:

ARVO Annual Meeting Abstract June 2020

Comparison of glucose metabolism in human macula and peripheral retina

Ting Zhang; Shaoxue Zeng; Michele C Madigan; Meidong Zhu; Jianhai Du; Weiyong Shen; Ling Zhu; Mark C Gillies

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3539. doi:

ARVO Annual Meeting Abstract June 2020

Association between anatomical and clinical outcomes in patients treated with anti-vascular endothelial growth factor for neovascular age-related macular degeneration

Mark C Gillies; Vuong Nguyen; Calvo Pilar; Martin Puzo; Pierre-Henry GABRIELLE; Catherine P Creuzot Garcher; Florian Baudin; Benjamin Wolff; Louise O’ Toole; Laurent Castelnovo; Michel Guillaume; Daniel Barthelmes

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4214. doi:

ARVO Annual Meeting Abstract June 2020

Ranibizumab or Aflibercept for Diabetic Macular Edema: One-Year Comparison of Real-World Outcomes from Fight Retinal Blindness! Registry.

SANJEEB BHANDARI; Vuong Nguyen; Samantha Fraser-Bell; Hemal Mehta; Francesco Viola; Florian Baudin; Pierre-Henry Gabrielle; Catherine P Creuzot Garcher; Mark C Gillies; Daniel Barthelmes

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3289. doi:

Genetics September 2019

MicroRNA-Related Genetic Variants Are Associated With Diabetic Retinopathy in Type 1 Diabetes Mellitus

PDF

Ebony Liu; Georgia Kaidonis; Bennet J. McComish; Mark C. Gillies; Sotoodeh Abhary; Rohan W. Essex; John H. Chang; Bishwanath Pal; Mark Daniell; Stewart Lake; Nikolai Petrovsky; Alex W. Hewitt; Alicia Jenkins; Ecosse L. Lamoureux; Jonathan M. Gleadle; Jamie E. Craig; Kathryn P. Burdon
TAGS: diabetes mellitus, type 1, diabetic retinopathy, genes, genetics, micrornas, single nucleotide polymorphism
Invest. Ophthalmol. Vis. Sci.. 2019; 60(12):3937-3942. doi: https://doi.org/10.1167/iovs.18-25570

Includes: Supplemental Content

ARVO Annual Meeting Abstract July 2019

A randomised clinical trial of slow versus fast intravitreal injection of ranibizumab (Lucentis®) and its impact on intraocular pressure (the Speed IOP Study)

Samantha Fraser-Bell; Sophia Zagora; Hemal Mehta; Anna Campain; Hon Seng Wong; Yeung Aaron; Mark C Gillies

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):79. doi:

1 2 3 4 5

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Filters

Specify Date Range

Incidence, Risk Factors and Outcomes of Submacular Hemorrhage with Loss of Vision in Neovascular Age-Related Macular Degeneration in Daily Clinical Practice: the Fight Retinal Blindness! Registry

Jak/STAT signalling mediated glia-neuron interaction following MAPK inhibition

Reprogramming of serine and glycine synthesis pathway in the JR5558 mouse model of retinal fibrosis

Metallothionein is activated specifically in Müller cells in response to retinal stress

36-month outcomes of VEGF inhibitors for treatment-naïve Central Retinal Vein Occlusion: Data from the Fight Retinal Blindness! registry.

Three-Year Outcomes of Neovascular Age-Related Macular Degeneration in Eyes That Do Not Develop Macular Atrophy or Subretinal Fibrosis

Extending interoperability in ophthalmology through Fast Healthcare Interoperability Resource (FHIR)

Disruption of the pentose phosphate pathway in Müller cells makes them more susceptible to light stress by interfering with the oxidative stress-induced NRF2 response

JR5558 transgenic mice are a reliable model to investigate subretinal fibrosis

Quality of life impact of eye diseases: a Save Sight Registries study

COVID-19 pandemic lockdown international impact on nAMD, DME and RVO intravitreal therapy outcomes: Fight Retinal Blindness International registry

Variation in visual outcomes for neovascular age-related macular degeneration within and between practitioners

Disease Activity Assessments with Brolucizumab vs Aflibercept in Patients with nAMD in HAWK and HARRIER

Towards retinal regeneration: Reprogramming retinal glial cells into photoreceptors using CRISPRa

PD98059 inhibits the activation of mitogen-activated protein kinase in stressed Müller cells and protects photoreceptor from degeneration

Comparison of glucose metabolism in human macula and peripheral retina

Association between anatomical and clinical outcomes in patients treated with anti-vascular endothelial growth factor for neovascular age-related macular degeneration

Ranibizumab or Aflibercept for Diabetic Macular Edema: One-Year Comparison of Real-World Outcomes from Fight Retinal Blindness! Registry.

MicroRNA-Related Genetic Variants Are Associated With Diabetic Retinopathy in Type 1 Diabetes Mellitus

A randomised clinical trial of slow versus fast intravitreal injection of ranibizumab (Lucentis®) and its impact on intraocular pressure (the Speed IOP Study)

To View More...

You must be signed into an individual account to use this feature.